FDA Clears SANSA ECG for Arrhythmia Detection at Home
Atlanta, December 18, 2025 — Huxley Medical, Inc. announced that its SANSA® home sleep apnea test has received U.S....
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Atlanta, December 18, 2025 — Huxley Medical, Inc. announced that its SANSA® home sleep apnea test has received U.S....
